Finance

Lists
Why is PHR up 2,88%?
Dive Deeper
PHR:NYSE
Phreesia Inc
USD 10,37
+2,88%
(+0,29) 1D
USD 10,37
0,00% (0,00)
Pre-market
Closed: 5 Okt., 16:00:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHR...
Open
USD 10,12
High
USD 10,49
Low
USD 10,09
Mkt. cap
643,68 m
Avg. vol.
719,51 k
Volume
0,00
P/E ratio
61,39
52-wk high
USD 24,24
52-wk low
USD 7,77
EPS
USD 0,17
Beta
0,84
Shares outstanding
62,07 m
No. of employees
2 k
Open
USD 10,12
High
USD 10,49
Low
USD 10,09
Mkt. cap
643,68 m
Avg. vol.
719,51 k
Volume
0,00
P/E ratio
61,39
52-wk high
USD 24,24
52-wk low
USD 7,77
EPS
USD 0,17
Beta
0,84
Shares outstanding
62,07 m
No. of employees
2 k
News stories
From web sources and news partners
Profile
Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake. Wikipedia
About Phreesia Inc
CEOChaim Indig
Employees1,79 k
Founded2005
HeadquartersWilmington, Delaware, Verenigde State van Amerika
SectorHealth care
Analyst ratings
Based on 11 analysts giving stock ratings to PHR in the past 3 months
Buy
Buy
6
Hold
5
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for PHR in the last 3 months.
Highest
Current USD 10,37
USD 19,00 (+83,22%)
Average
USD 13,22 (+27,48%)
Lowest
USD 10,00 (-3,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Daniels
William Blair
Buy
Maintained
-
-
10/02/2026
Parker Snure
Raymond James
Hold
Downgraded
USD 12,00
+15,7%
09/08/2026
Joseph Vruwink
Robert W. Baird
Hold
Maintained
USD 11,00
+6,1%
09/04/2026
Clark Wright
D.A. Davidson
Buy
Maintained
USD 13,00
+25,4%
09/04/2026
Jailendra Singh
Truist Financial
Hold
Maintained
-
-
09/03/2026
Ryan Halsted
RBC Capital
Buy
Maintained
USD 19,00
+83,2%
09/03/2026
Richard Close
Canaccord Genuity
Buy
Maintained
USD 16,00
+54,3%
09/03/2026
Stan Berenshteyn
Wells Fargo
Hold
Reiterated
USD 10,00
-3,6%
09/03/2026
Ryan MacDonald
Needham
Buy
Reiterated
USD 14,00
+35%
09/03/2026
Glen Santangelo
Barclays
Hold
Maintained
USD 10,00
-3,6%
09/03/2026
Eugene Mannheimer
Freedom Capital Markets
Buy
Reiterated
USD 14,00
+35%
09/03/2026
Alexei Gogolev
J.P. Morgan
Hold
Reiterated
USD 14,00
+35%
06/25/2026
Sean Dodge
BMO Capital
Buy
Maintained
USD 14,00
+35%
06/22/2026
Jessica Tassan
Piper Sandler
Hold
Downgraded
USD 12,00
+15,7%
05/28/2026
Unknown Analyst
Jefferies
Buy
Maintained
USD 20,00
+92,9%
05/28/2026
Dan Waggoner
D.A. Davidson
Buy
Maintained
USD 14,00
+35%
05/28/2026
Daniel Grosslight
Citi
Hold
Reiterated
USD 12,00
+15,7%
05/28/2026
Unknown Analyst
KeyBanc
Buy
Reiterated
USD 12,00
+15,7%
04/13/2026
Scott Schoenhaus
KeyBanc
Buy
Reiterated
USD 12,00
+15,7%
04/13/2026
Aaron Kimson
Citizens JMP
Hold
Downgraded
-
-
04/01/2026
Jeffrey Garro
Stephens
Buy
Maintained
USD 20,00
+92,9%
03/31/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
USD 19,00
+83,2%
03/24/2026
Last report
02 Sep. 2026
Fiscal period
Q2 2027
EPS / Est. (USD)
USD 0,28 / USD 0,32
-14,34%miss
Revenue / Est. (USD)
129,46 m / 128,99 m
+0,36%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Okt. 2025
Jan. 2026
Apr. 2026
Jul. 2026
Revenue
120,33 m
127,07 m
130,94 m
129,46 m
Cost of goods sold
38,03 m
40,39 m
43,33 m
43,18 m
Cost of revenue
38,03 m
40,39 m
43,33 m
43,18 m
Research and development expenses
29,45 m
30,92 m
28,33 m
27,57 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39,66 m
44,37 m
42,57 m
41,10 m
Operating expense
76,59 m
84,98 m
80,85 m
78,66 m
Total operating expenses
114,62 m
125,37 m
124,19 m
121,85 m
Operating income
5,71 m
1,69 m
6,75 m
7,61 m
Other non operating income
1,01 m
1,27 m
-7,00 k
-2,89 m
EBT including unusual items
5,12 m
-10,32 m
4,72 m
3,24 m
EBT excluding unusual items
7,10 m
-2,57 m
4,74 m
3,24 m
Income tax expense
854,00 k
-11,62 m
1,76 m
1,32 m
Effective tax rate
16,66%
112,54%
37,26%
40,78%
Other operating expenses
-
-
-
-
Net income
4,27 m
1,30 m
2,96 m
1,92 m
Net profit margin
3,55%
1,02%
2,26%
1,48%
Earnings per share
0,31
0,44
0,27
0,28
Interest and investment income
700,00 k
269,00 k
297,00 k
248,00 k
Interest expense
-320,00 k
-5,81 m
-2,30 m
-1,73 m
Net interest expenses
380,00 k
-5,54 m
-2,00 m
-1,48 m
Depreciation and amortization charges
3,20 m
3,51 m
3,37 m
3,34 m
EBITDA
13,19 m
7,67 m
12,73 m
13,58 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme